Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma : An Evidence Review Group Evaluation of the NICE Single Technology Appraisal.
Pharmacoeconomics
; 37(8): 975-984, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-30547368
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, Follicular
/
Quality-Adjusted Life Years
Type of study:
Clinical_trials
/
Guideline
/
Health_economic_evaluation
/
Health_technology_assessment
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2019
Type:
Article
Affiliation country:
Netherlands